Assessment of cellular and molecular pathways in the human fibrotic precision cut lung slice after cryopreservation
Disease Models & Mechanisms · 2026-11-06
DOI: 10.1242/dmm.052773 ↗Abstract
Precision-cut lung slices (PCLS) are a promising approach in lung biology, but their use as a model for pulmonary fibrosis (PF) is limited. To prolong tissue viability, we use cryopreservation and test if cryopreserved human PF PCLS retains cellular, transcriptional, and functional regulation of effector cell types/states.Compared to published findings with never-frozen human PF PCLS, cryopreserved-thawed human PF PCLS retained key features, including fibroblast/myofibroblast accumulation, epithelial depletion, and vascular remodeling. These changes were spatially coincident with collagen-rich ECM-related genes (e.g., COL1A1, SPARC), expanded fibroblast-endothelial crosstalk (CXCL12–CXCR4), integrin-driven mesenchymal signaling (ANGPTL–integrin), stress-adapted, immune-interacting Alveolar Type 2 cells with reduced surfactant expression, and profibrotic endothelial reprogramming. Fibrotic niche indicated increased immune responses (IGKC and IGHG1), fibrosis (collagen and fibronectin), Mechan transduction (MYH11, TPM2), immune cell recruitment (CCL2, IL6), ECM remodeling (THBS1), and decreased surfactant genes (SFTPB, SFTPC). Functionally, fibrotic niches exhibited activation of fibroblast-mediated pathways: the matricellular glycoprotein SPARC, Relaxin signaling, and multiple immunoglobulin transcripts, including IGHA1 and IGHG1. We verify model fidelity, identify known and new pro-fibrotic genes, and support cryopreserved human PF PCLS for disease modeling and drug discovery.
EUVIMED